GLI1 and cancer: Since both canonical and noncanonical axis culminates in GLI-mediated transcription, GLI protein represents the most promising target for cancer therapy; for instance, drugs that target GLI function such as GANT61 have been shown to exert superior anti-cancer therapy compared to upstream targets [66,67,68].